Lung cancer is the second most common cancer and the leading cause of cancer death in the United States.1 For all cancers, early detection is essential to better outcomes, and discovering lung cancer at an early stage leads to more successful treatment and a better prognosis.
In March 2021, the U.S. Preventive Services Task Force (USPSTF) updated their eligibility recommendations for low-dose computed tomography (LDCT) by lowering the pack-year amount and expanding the age range to allow more people to qualify for the screening.
The USPSTF qualifications now include:
